APLM
Apollomics Inc.
NASDAQ · Healthcare · Biotechnology · US
$22.05
+4.49%Next report
Analyst consensus
- Next report date
- Apr 1, 2027
- EPS estimate
- —
- Revenue estimate
- —
Latest reported
- Last report date
- Jun 30, 2024
- EPS actual
- -$38
- EPS estimate
- —
- Revenue actual
- $1.8M
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -159533.5%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jun 30, 2024 | — | -$38 | — | $1.8M |
| Dec 30, 2023 | — | -$24 | — | $333.0K |
| Jul 28, 2023 | -$0.16 | -$255 | Miss -159533.48% | $488.0K |
| Dec 31, 2022 | — | -$274 | — | -$272.0K |
| Jun 30, 2022 | — | -$25 | — | $595.0K |
| Jun 30, 2021 | — | -$18 | — | $55.0K |
| Dec 31, 2020 | — | -$8.75 | — | — |
| Jun 30, 2020 | — | -$50 | — | $1.8M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Apr 1, 2027